RemediumOne (@remediumone) 's Twitter Profile
RemediumOne

@remediumone

RemediumOne is Sri Lanka’s pioneering clinical research company with research management services

ID: 1559765324743983108

linkhttps://www.remediumone.com/ calendar_today17-08-2022 04:53:43

9 Tweet

9 Followers

10 Following

AEGIS (@aegisprogram) 's Twitter Profile Photo

Ramping up for our Aedes-borne virus cRCT in Sri Lanka working with partners including National Dengue Control Unit, RemediumOne, and Dr. Neelika Malavige Learn more about the trial here: aegis.nd.edu/our-approach/t…

AEGIS (@aegisprogram) 's Twitter Profile Photo

The dengue trial Site Evaluation Visit has begun! @FHIClinical visited National Dengue Control Unit and the rest of our Sri Lankan partners to discuss site readiness, staffing, and training. We wish them a successful meeting and fruitful discussions.

The dengue trial Site Evaluation Visit has begun! @FHIClinical visited <a href="/DengueUnit/">National Dengue Control Unit</a> and the rest of our Sri Lankan partners to discuss site readiness, staffing, and training. We wish them a successful meeting and fruitful discussions.
RemediumOne (@remediumone) 's Twitter Profile Photo

RemediumOne will be coordinating a medical device trial in Sri Lanka soon. The study is designed to find innovative solution for stroke reduction. A scientific meeting took place at National Hospital of Sri Lanka yesterday. #neurology #radiology #stroke #clinicaltrials #srilanka

RemediumOne will be coordinating a medical device trial in Sri Lanka soon. The study is designed to find innovative solution for stroke reduction. A scientific meeting took place at National Hospital of Sri Lanka yesterday.

#neurology #radiology #stroke #clinicaltrials #srilanka
RemediumOne (@remediumone) 's Twitter Profile Photo

Final benefitaries of clinical research industry are patients. Any drug comes to the shelve goes through clinical trials. Conducting clinical trials with utmost care is a commitment. Thank You Dr. Gotabhaya Ranasinghe for spearheading cardiology medical research in Sri Lanka.

Final benefitaries of clinical research industry are patients. Any drug comes to the shelve goes through clinical trials. Conducting clinical trials with utmost care is a commitment. Thank You  Dr. Gotabhaya Ranasinghe for spearheading cardiology medical research in Sri Lanka.
RemediumOne (@remediumone) 's Twitter Profile Photo

RemediumOne is delighted with another infrastructure upgrade project at Colombo South Teaching Hospital - Neurology Centre. #clinicaltrials #clinicalresearch #upgrade #neurology #SriLanka #RemediumOne

RemediumOne is delighted with another infrastructure upgrade project at Colombo South Teaching Hospital - Neurology Centre.

#clinicaltrials #clinicalresearch #upgrade #neurology #SriLanka #RemediumOne
RemediumOne (@remediumone) 's Twitter Profile Photo

Interactive session with Investigators at Jaffna Teaching Hospital. Thank You All very much for your valuable time and inputs. Enhanced cure comes through evidence based medicine. #clinicalresearch #jaffnasrilanka #clinicaltrials #evidencebasedmedicine #investigators #engagement

Interactive session with Investigators at Jaffna Teaching Hospital. Thank You All very much for your valuable time and inputs. Enhanced cure comes through evidence based medicine.
#clinicalresearch #jaffnasrilanka #clinicaltrials #evidencebasedmedicine #investigators #engagement
RemediumOne (@remediumone) 's Twitter Profile Photo

RemediumOne is excited to partner with University of Notre Dame and FHI Clinical Inc. in managing AEGIS program (Spatial repellents for dengue prevention). This program is exploring the effectiveness of spatial repellents in dengue control in countries with dengue endemic.

RemediumOne is excited to partner with University of Notre Dame and FHI Clinical Inc. in managing AEGIS program (Spatial repellents for dengue prevention). This program is exploring the effectiveness of spatial repellents in dengue control in countries with dengue endemic.
RemediumOne (@remediumone) 's Twitter Profile Photo

Sri Lanka will start recruiting pariticipants for an IgAN phase III global program in Aug/Sep 2022. #nephrology #clinicalresearch #clinicaltrials #srilanka #globalhealth #researchanddevelopment

Sri Lanka will start recruiting pariticipants for an IgAN phase III global program in Aug/Sep 2022. 
#nephrology #clinicalresearch #clinicaltrials #srilanka #globalhealth #researchanddevelopment